EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study

Rossano Girometti iD, Valeria Peruzzi, Paolo Polizzi, Maria De Martino, Lorenzo Cereser, Letizia Casarotto, Stefano Pizzolitto, Miriam Isola, Alessandro Crestani, Gianluca Giannarini, Chiara Zuiani

Abdominal Radiology · 2024

DOI: 10.1007/s00261-024-04506-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, 2024. Verfasst von Rossano Girometti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiology, Department of Medicine (DMED), University of Udine, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Unive…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Udine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To retrospectively investigate whether a case-by-case combination of the Prostate Imaging Reporting and Data System version 2.1 (PI-RADS) with the Likert score improves the diagnostic performance of mpMRI for clinically significant prostate cancer (csPCa), especially by reducing false-positives.

Methods

One hundred men received mpMRI between January 2020 and April 2021, followed by prostate biopsy. Reader 1 (R1) and reader 2 (R2) (experience of > 3000 and < 200 mpMRI readings) independently reviewed mpMRIs with the PI-RADS version 2.1. After unveiling clinical information, they were free to add (or not) a Likert score to upgrade or downgrade or reinforce the level of suspicion of the PI-RADS category attributed to the index lesion or, rather, identify a new index lesion. We calculated sensitivity, specificity, and predictive values of R1/R2 in detecting csPCa when biopsying PI-RADS ≥ 3 index-lesions (strategy 1) versus PI-RADS ≥ 3 or Likert ≥ 3 index-lesions (strategy 2), with decision curve analysis to assess the net benefit. In strategy 2, the Likert score was considered dominant in determining biopsy decisions. Results csPCa prevalence was 38%. R1/R2 used combined PI-RADS and Likert categorization in 28%/18% of examinations relying mainly on clinical features such as prostate specific antigen level and digital rectal examination than imaging findings. The specificity/positive predictive values were 66.1/63.1% for R1 (95%CI 52.9–77.6/54.5–70.9) and 50.0/51.6% (95%CI 37.0-63.0/35.5-72.4%) for R2 in the case of PI-RADS-based readings, and 74.2/69.2% for R1 (95%CI 61.5–84.5/59.4–77.5%) and 56.6/54.2% (95%CI 43.3-69.0/37.1-76.6%) for R2 in the case of combined PI-RADS/Likert readings. Sensitivity/negative predictive values were unaffected. Strategy 2 achieved greater net benefit as a trigger of biopsy for R1 only.

Conclusion

Case-by-case combination of the PI-RADS version 2.1 with Likert score translated into a mild but measurable impact in reducing the false-positives of PI-RADS categorization, though greater net benefit in reducing unnecessary biopsies was found in the experienced reader only. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMagnetic Resonance ImagingMaleHumansRetrospective StudiesAgedMiddle AgedFalse Positive ReactionsProof of Concept StudySensitivity and SpecificityProstateRadiology Information Systems

Stichwörter der Autor:innen

BiopsyMultiparametric magnetic resonance imagingPI-RADSProstatic neoplasms

Autor:innen und Institutionen

  • Institute of Radiology, Department of Medicine (DMED), University of Udine, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Universitaria Friuli Centrale (ASU FC), p.le S. Maria della Misericordia, 1…
  • UOC Radiologia, Ospedale Civile SS. Giovanni e Paolo, ULSS 3 Serenissima, 6776 - 30122, Castello, Venezia, Italy.
  • Division of Medical Statistics, Department of Medicine (DMED), University of Udine, pl.le Kolbe, 4 - 33100, Udine, Italy.
  • Pathology Unit, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Universitaria Friuli Centrale (ASU FC), p.le S. Maria della Misericordia, 15 - 33100, Udine, Italy.
  • Urology Unit, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Universitaria Friuli Centrale (ASU FC), p.le S. Maria della Misericordia, 15 - 33100, Udine, Italy.

ORCID-Profile: Rossano Girometti

Förderung

  • Università degli Studi di Udine

Zitieren

APA

Girometti, R., Peruzzi, V., Polizzi, P., De Martino, M., Cereser, L., Casarotto, L., Pizzolitto, S., Isola, M., Crestani, A., Giannarini, G., & Zuiani, C. (2024). Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study. Abdominal Radiology. https://doi.org/10.1007/s00261-024-04506-2

Vancouver

Girometti R, Peruzzi V, Polizzi P, De Martino M, Cereser L, Casarotto L, et al. Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study. Abdominal Radiology. 2024. doi:10.1007/s00261-024-04506-2

BibTeX
@article{Girometti2024,
  author = {Girometti, Rossano and Peruzzi, Valeria and Polizzi, Paolo and De Martino, Maria and Cereser, Lorenzo and Casarotto, Letizia and Pizzolitto, Stefano and Isola, Miriam and Crestani, Alessandro and Giannarini, Gianluca and Zuiani, Chiara},
  title = {Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study},
  journal = {Abdominal Radiology},
  year = {2024},
  doi = {10.1007/s00261-024-04506-2}
}
Kostenlos starten →